Abstract
Mechanisms of hepatocyte proliferation triggered by tissue loss are distinguishable from those that promote proliferation in the intact liver in response to mitogens. Previous studies demonstrate that exogenous activation of the aryl hydrocarbon receptor (AhR), a soluble ligand-activated transcription factor in the basic helix-loop-helix family of proteins, suppresses compensatory liver regeneration elicited by surgical partial hepatectomy. The goal of the present study was to determine how AhR activation modulates hepatocyte cell cycle progression in the intact liver following treatment with the hepatomitogen, 1,4-bis[2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP). Mice were pretreated with the exogenous AhR agonist 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 24h prior to treatment with TCPOBOP (3 mg/kg).). In contrast to the suppressive effects of AhR activation observed during compensatory regeneration, TCDD pretreatment resulted in a 30-50% increase in hepatocyte proliferation in the intact liver of TCPOBOP-treated mice. Although pretreatment with TCDD suppressed CDK2 kinase activity and increased the association of CDK2 with negative regulatory proteins p21Cip1 and p27Kip1, a corresponding increase in CDK4/cyclin D1 associat...Continue Reading
References
Apr 9, 1971·Science·J E Gielen, D W Nebert
Aug 1, 1995·Cell Proliferation·J W BaumanT R Fox
May 15, 1995·Genes & Development·C J Sherr, J M Roberts
Feb 15, 1994·Archives of Biochemistry and Biophysics·L BenedettiN J Bunce
May 1, 1996·Molecular and Cellular Biology·Q Ma, J P Whitlock
Jul 10, 1996·Experimental Cell Research·C WeissM Göttlicher
Sep 25, 1998·Oncogene·G M Ledda-ColumbanoA Columbano
Jan 7, 2000·The American Journal of Pathology·G M Ledda-ColumbanoA Columbano
Mar 18, 2000·The Journal of Biological Chemistry·Q Ma, K T Baldwin
Sep 6, 2002·Chemico-biological Interactions·Richard S Pollenz
Oct 24, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Giovanna M Ledda-ColumbanoAmedeo Columbano
Jan 27, 2004·Molecular Pharmacology·Aviva Levine-FridmanCornelis J Elferink
Oct 20, 2004·Molecular Pharmacology·Gengming Huang, Cornelis J Elferink
May 19, 2005·Journal of Comparative Physiology. B, Biochemical, Systemic, and Environmental Physiology·Prabir K Mandal
Oct 19, 2005·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Amedeo ColumbanoJoseph Locker
Nov 23, 2005·Proceedings of the National Academy of Sciences of the United States of America·Jacqueline A WalisserChristopher A Bradfield
Feb 1, 2006·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Nelson FaustoKimberly J Riehle
Sep 16, 2006·Molecular Nutrition & Food Research·Stefanie Knerr, Dieter Schrenk
Jul 14, 2007·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Jay S Petrick, Curtis D Klaassen
Nov 26, 2008·Biochemical Pharmacology·Kristen A Mitchell, Cornelis J Elferink
Nov 18, 2009·Molecular Pharmacology·Melissa A BarhooverRussell S Thomas
Citations
Feb 22, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Althea ElliottJohn J Reiners
Dec 1, 2012·Archives of Toxicology·Dagmar FaustMiroslav Machala
Aug 20, 2011·Toxicology and Applied Pharmacology·Anna K KopecTimothy R Zacharewski
Jun 9, 2016·Stem Cells International·Jan Vondráček, Miroslav Machala
Dec 28, 2012·The Journal of Pharmacology and Experimental Therapeutics·Tod A HarperCornelis J Elferink
Mar 21, 2013·The Journal of Pharmacology and Experimental Therapeutics·Shelly R WilsonCornelis J Elferink
Jan 17, 2014·Molecular Pharmacology·Daniel P JacksonCornelis J Elferink
Jan 20, 2016·Toxicology Research·D P JacksonC J Elferink